Press Room

Share

President Biden Commits to “End Cancer As We Know It” in Address to Congress

Statement from American Cancer Society Cancer Action Network (ACS CAN) President Lisa Lacasse

April 28, 2021

WASHINGTON D.C. – April 28, 2021 – “We are thrilled President Biden has committed to a huge investment in the fight against cancer. We urge the administration to both prioritize innovation and sustain robust funding for cancer research at the National Institutes of Health and National Cancer Institute that has saved countless lives over the last half century. Every major cancer research breakthrough of the last 50 years is due to federal funding. ACS CAN looks forward to working with the Biden Administration to accelerate cancer research and discovery.”

More Press Releases AboutCancer Research Funding, National

Media Contacts

Alissa Crispino
VP, Advocacy Communications and Policy
Washington
[email protected]
202.661.5772

Related Press Releases

April 8, 2025

Maryland State Budget Produces Mixed Results in Fight against Cancer

Maryland state lawmakers have released details on the agreed upon 2025-26 budget—the contents of which are a mixed bag in the fight against cancer. While the state made sound investments in cancer research and protected Medicaid recipients’ ability to access biomarker testing, it missed an opportunity to save the lives and lungs of Maryland’s youth by cutting funding for the state’s tobacco prevention and cessation programs.

Read More
March 26, 2025

U.S. Senate Confirms Jay Bhattacharya as Director of the National Institutes of Health

Yesterday, the U.S. Senate voted to confirm Jay Bhattacharya, MD, PhD, as the new director of the National Institutes of Health (NIH).

Read more
March 11, 2025

U.S. House Misses Critical Opportunity to Boost Cancer Research and Prevention Funding; Future Progress in Jeopardy

Today, the U.S. House passed The Full-Year Continuing Appropriations and Extensions Act, 2025. It contains no increases for federal cancer research or prevention funding and significant cuts to Congressionally Directed Medical Research Programs (CDMRP), in which cancer is the largest recipient of funds. 

Read more